INDIANAPOLIS, Sept. 24, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) is voluntarily recalling lot D239382D, Expiration April 2022, of Glucagon Emergency Kit for Low Blood Sugar (Glucagon for ...
Eli Lilly recalled an emergency kit that can save the lives of people with diabetes having severe hypoglycemia. The reason: “loss of potency” after the kit failed a customer who needed it. Here’s what ...
Eli Lilly and Co. on Saturday recalled a single lot of its Glucagon Emergency Kit for Low Blood Sugar, following a patient complaint. The recall affects only lot D239382D, with an expiration date of ...
CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use ...
Eli Lilly recalled an emergency kit that can save the lives of people with diabetes having severe hypoglycemia. The reason: “loss of potency” after the kit failed a customer who needed it. Here’s what ...
INDIANAPOLIS — Eli Lilly and Co. on Saturday recalled a single lot of its Glucagon Emergency Kit for Low Blood Sugar, following a patient complaint. The recall affects only lot D239382D, with an ...
Eli Lilly is voluntarily recalling one lot of glucagon emergency kits at the patient level after a product complaint reporting a vial of glucagon was in liquid instead of powder form, according to an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback